
ORYZON Awarded €13.26 Million Through the First Important Project of Common European Interest (IPCEI) in the Health ...
Approximately 15 million USD Oryzon to validate epigenetic agents by applying a personalized medicine approach for rare and orphan diseases Oryzon will explore Aggression in specific subsets of Autism Spectrum Disorder (ASD) to expand the precision …